Epigenetics and Transcriptomics Core
表观遗传学和转录组学核心
基本信息
- 批准号:10706503
- 负责人:
- 金额:$ 33.23万
- 依托单位:
- 依托单位国家:美国
- 项目类别:
- 财政年份:2022
- 资助国家:美国
- 起止时间:2022-09-20 至 2027-08-31
- 项目状态:未结题
- 来源:
- 关键词:ATAC-seqAnti-Inflammatory AgentsBiogenesisBioinformaticsBiological AssayBiological Response ModifiersBiometryBlood CellsBlood VesselsCell CountCell physiologyCell surfaceCellsChIP-seqChromatinCoupledDataData AnalyticsData FilesData SetData Storage and RetrievalDevelopmentDimensionsEndoplasmic ReticulumEndothelial CellsEndotheliumEnvironmentEpigenetic ProcessEventFoundationsGene ExpressionGenerationsGenesGeneticGenetic TranscriptionGenomeGenomicsGoalsGrantHomeostasisImmuneImmune signalingIndividualInfectionInflammationInflammatory ResponseInjuryInnate Immune SystemInvestigationLibrariesLungMapsMethodologyMethodsMiningMitochondriaModelingMolecularNatural ImmunityNeutrophil ActivationOrganPathway interactionsPhagocytesPreparationProcessProductionPulmonary CirculationReproducibilityResolutionRoleSamplingScanningSignal InductionSignal PathwaySignal TransductionSphingosine-1-Phosphate ReceptorStandardizationSystemTechnologyTestingValidationanalytical toolcomparativedata integrationdata sharingepigenomicsgene networkgene regulatory networkgenome-wideinjury and repairlung injurylung repairnext generation sequencingprogramspulmonary functionrepair modelresponsestem cellstranscriptome sequencingtranscriptomic profilingtranscriptomicsubiquitin-protein ligasevascular injury
项目摘要
ABSTRACT
The function of the Epigenetics and Transcriptomics Core (Core B) is to identify the key gene networks and
cis-regulatory mechanisms that define the pulmonary endothelium as an innate immune ‘organ’ during lung injury
and repair. Core B will provide high-throughput production and optimal mining of genome-wide gene expression
and chromatin datasets, for all three projects in this Program. The Core B leader has pioneered such
approaches in stem cells and is now applying these analysis platforms to lung endothelial cells in a
comprehensive and integrative manner. We have optimized the methods for several next generation sequencing
approaches, including low cell number RNA-seq, ChIP-seq and ATAC-seq, and can effectively collect, manage,
analyze, integrate, and interpret the generated data specifically in freshly isolated endothelial cells. By combining
all four technologies we will develop a multi-dimensional view of the epigenetic programming of endothelial cells
(EC) and reveal their modulatory interactions with circulating immune cells. On this basis, Core B will provide a
foundation for the more specific and sophisticated needs of each individual project. Indeed, each project focuses
on gene regulatory networks that are among the most robustly regulated across lung injury and repair models.
Through the development and use of epigenetic and transcriptomic assays coupled with next generation
sequencing, Core B will assist each Project in uncovering the molecular mechanisms and develop testable
hypothesis about genes associated with EC innate immunity and their role in inflammatory response. These
include the exploration of the epigenetic and transcriptomic changes that occur in response to endoplasmic
reticulum localized Y143phosphorylated sphingosine 1 phosphate receptor 1 (S1PR1), as EC convert from an
anti-inflammatory to an immune-active lineage in Project 1; delineate the cis-regulatory mechanisms and
chromatin-based pathways that control the expression of ubiquitin E3 ligase CHFR in Project 2; and examine
the role of epigenetic programs in the initiation of lung endothelial cell mitophagy and mitochondrial biogenesis
as well as the downstream effectors of mitophagy-induced signals in Project 3. Ultimately, Core B represents a
central conduit for genomic and bioinformatic flow of data for this PPG, providing data-generation, data-storage
and data-sharing functions and therefore contributing significantly to further understanding the immune
regulatory function of lung endothelium.
抽象的
表观遗传学和转录组学核心(Core B)的功能是识别关键基因网络和
将肺内皮定义为肺损伤期间的先天免疫“器官”的顺式调节机制
Core B 将提供高通量生产和全基因组基因表达的优化挖掘。
和染色质数据集,对于该计划的所有三个项目,Core B 领导者都是此类项目的先驱。
干细胞方法,现在正在将这些分析平台应用于肺内皮细胞
我们以全面、综合的方式优化了几种下一代测序的方法。
方法,包括低细胞数RNA-seq、ChIP-seq和ATAC-seq,并且可以有效地收集、管理、
通过组合,专门在新鲜分离的内皮细胞中分析、整合和解释生成的数据。
通过所有四种技术,我们将开发内皮细胞表观遗传编程的多维视图
(EC) 并揭示它们与循环免疫细胞的调节相互作用。在此基础上,Core B 将提供一个
事实上,每个项目都侧重于满足更具体和更复杂的需求。
基因调控网络是肺损伤和修复模型中受到最严格调控的网络之一。
通过开发和使用表观遗传和转录组分析以及下一代
测序,Core B将协助每个项目揭示分子机制并开发可测试的
关于与 EC 先天免疫相关的基因及其在炎症反应中的作用的假设。
包括探索内质反应中发生的表观遗传和转录组变化
网状局部 Y143 磷酸化鞘氨醇 1 磷酸受体 1 (S1PR1),作为 EC 从
项目 1 中对免疫活性谱系的抗炎作用描述了顺式调节机制;
项目2中基于染色质的控制泛素E3连接酶CHFR的表达;
表观遗传程序在肺内皮细胞线粒体自噬和线粒体生物发生启动中的作用
以及项目 3 中线粒体自噬诱导信号的下游效应器。最终,核心 B 代表了
该 PPG 的基因组和生物信息数据流的中央管道,提供数据生成、数据存储
和数据共享功能,因此大大有助于进一步了解免疫系统
肺内皮的调节功能。
项目成果
期刊论文数量(0)
专著数量(0)
科研奖励数量(0)
会议论文数量(0)
专利数量(0)
数据更新时间:{{ journalArticles.updateTime }}
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
数据更新时间:{{ journalArticles.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ monograph.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ sciAawards.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ conferencePapers.updateTime }}
{{ item.title }}
- 作者:
{{ item.author }}
数据更新时间:{{ patent.updateTime }}
Konstantinos Chronis其他文献
Konstantinos Chronis的其他文献
{{
item.title }}
{{ item.translation_title }}
- DOI:
{{ item.doi }} - 发表时间:
{{ item.publish_year }} - 期刊:
- 影响因子:{{ item.factor }}
- 作者:
{{ item.authors }} - 通讯作者:
{{ item.author }}
{{ truncateString('Konstantinos Chronis', 18)}}的其他基金
Reprogramming Gene Regulatory Networks to a Hematopoietic Stem Cell State
将基因调控网络重编程为造血干细胞状态
- 批准号:
10716641 - 财政年份:2023
- 资助金额:
$ 33.23万 - 项目类别:
相似国自然基金
靶向HDAC3/SIAH2蛋白复合物的HDAC3降解剂的作用机制、结构改造及非酶活功能介导的抗炎活性研究
- 批准号:
- 批准年份:2022
- 资助金额:30 万元
- 项目类别:青年科学基金项目
卡萨烷选择性调控糖皮质激素受体GR功能的抗炎作用机制与新颖调控剂的设计与发现
- 批准号:82273824
- 批准年份:2022
- 资助金额:52 万元
- 项目类别:面上项目
ZAP-70选择性共价抑制剂及降解剂的设计合成和抗炎活性研究
- 批准号:
- 批准年份:2021
- 资助金额:30 万元
- 项目类别:青年科学基金项目
基于片段的P2Y14受体拮抗剂的设计、合成和抗炎活性研究
- 批准号:
- 批准年份:2020
- 资助金额:55 万元
- 项目类别:面上项目
两种民族药用植物中黄酮类ILCreg诱导剂的发现及其抗炎性肠病机制探究
- 批准号:81960777
- 批准年份:2019
- 资助金额:34 万元
- 项目类别:地区科学基金项目
相似海外基金
The 11S-associated immunoproteasome in mitochondrial function and metabolic disorders
线粒体功能和代谢紊乱中的 11S 相关免疫蛋白酶体
- 批准号:
10681643 - 财政年份:2023
- 资助金额:
$ 33.23万 - 项目类别:
Brain derived extracellular vesicles-mediated neurotoxicity of deltamethrin
溴氰菊酯脑源性细胞外囊泡介导的神经毒性
- 批准号:
10679858 - 财政年份:2023
- 资助金额:
$ 33.23万 - 项目类别:
Mechanisms underlying prescription opioid use post social defeat in HIV+ adolescents
HIV 青少年社交失败后处方阿片类药物使用的潜在机制
- 批准号:
10700525 - 财政年份:2023
- 资助金额:
$ 33.23万 - 项目类别:
“Protection from MRSA lethality by inhibiting LXRα phosphorylation”
– 通过抑制 LXRα 磷酸化来防止 MRSA 致死 –
- 批准号:
10681027 - 财政年份:2023
- 资助金额:
$ 33.23万 - 项目类别: